Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis (original) (raw)

• Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449–1455 (1995).
  Article CAS Google Scholar
• Nagata, S. Apoptosis mediated by the Fas system. Prog. Mol. Subcell. Biol. 16, 87–103 (1996).
  Article CAS Google Scholar
• Galle, P.R. & Krammer, P.H. CD95-induced apoptosis in human liver disease. Semin. Liver Dis. 18, 141–151 (1998).
  Article CAS Google Scholar
• Kondo, T., Suda, T., Fukuyama, H., Adachi, M. & Nagata, S. Essential roles of the fas ligand in the development of hepatitis. Nat. Med. 3, 409–413 (1997).
  Article CAS Google Scholar
• Kuwano, K. et al. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104, 13–19 (1999).
  Article CAS Google Scholar
• Viard, I. et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490–493 (1998).
  Article CAS Google Scholar
• Dittel, B.N., Merchant, R.M. & Janeway, C.A.J. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162, 6392–6400 (1999).
  CAS Google Scholar
• Strater, J. et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113, 160–167 (1997).
  Article CAS Google Scholar
• Kong, L. et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 40, 87–97 (1997).
  Article CAS Google Scholar
• Giordano, C. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960–963 (1997).
  Article CAS Google Scholar
• Stassi, G. et al. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J. Immunol. 162, 263–267 (1999).
  CAS PubMed Google Scholar
• Josien, R. et al. Fas ligand, tumor necrosis facter-a expression, and apoptosis during allograft rejection and tolerance. Transplantation 66, 887–893 (1998).
  Article CAS Google Scholar
• Rudi, J. et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in _Helicobacter pylori_-induced gastric epithelial apoptosis. J. Clin. Invest. 102, 1506–1514 (1998).
  Article CAS Google Scholar
• Miwa, K. et al. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease. Int. Immunol. 11, 925–931 (1999).
  Article CAS Google Scholar
• Cooper, S.R., Taylor, J.K., Miraglia, L.J. & Dean, N.M. Pharmacology of antisense oligonucleotide inhibitors of protein expression. Pharmacol. Ther. 82, 427–435 (1999).
  Article CAS Google Scholar
• Crooke, S.T. Basic principles of antisense therapeutics. In Antisense research and application. (ed. Crooke, S.T.) 1–50 (Springer-Verlag, Berlin; 1998).
  Chapter Google Scholar
• Taylor, J.K., Zhang, Q.Q., Wyatt, J.R. & Dean, N.M. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat. Biotechnol. 17, 1097–1100 (1999).
  Article CAS Google Scholar
• Kole, R. Modification of pre-mRNA splicing by antisense oligonucleotides. Acta Biochimica Polonica 44, 231–238 (1997).
  CAS PubMed Google Scholar
• Dean, N.M., McKay, R., Condon, T.P. & Bennett, C.F. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269, 16416–16424 (1994).
  CAS PubMed Google Scholar
• Zhang, H. et al. Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV–vaccinia virus recombinant. Antimicrob. Agents Chemother. 43, 347–353 (1999).
  Article CAS Google Scholar
• Mizuta, T. et al. Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A. Nat. Biotechnol. 17, 583–587 (1999).
  Article CAS Google Scholar
• Bennett, C.F. et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J. Pharmacol. Exp. Ther. 280, 988–1000 (1997).
  CAS PubMed Google Scholar
• Noiri, E., Peresleni, T., Miller, F. & Goligorsky, M.S. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J. Clin. Invest. 97, 2377–2383 (1996).
  Article CAS Google Scholar
• Driver, S.E. et al. Oligonucleotide-based inhibition of embryonic gene expression. Nat. Biotechnol. 17, 1184–1187 (1999).
  Article CAS Google Scholar
• Crooke, S.T. Molecular mechanisms of antisense drugs: RNase H. Antisense Nucleic Acid Drug Dev. 8, 133–134 (1998).
  Article CAS Google Scholar
• McKay, R. et al. Characterization of a potent and specific class of antisense oligonucleotide inhibitors of human PKC-alpha expression. J. Biol. Chem. 274, 1715–1722 (1999).
  Article CAS Google Scholar
• Ksontini, R. et al. Disparate roles for TNF-α and fas ligand in concanavalin A-induced hepatitis. J. Immunol. 160, 4082–4089 (1998).
  CAS PubMed Google Scholar
• Watanabe, Y., Morita, M. & Akaike, T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 24, 702–710 (1996).
  Article CAS Google Scholar
• Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993).
  Article CAS Google Scholar
• Taieb, J., Mathurin, P., Poynard, T., Gougerot-Pocidalo, M.A. & Collet-Martin, S. Raised plasma-soluble fas and fas-ligand in alcoholic liver disease. Lancet 351, 1930–1931 (1998).
  Article CAS Google Scholar
• Ray, S.D., Mumaw, V.R., Ravindra, R., Fariss, R. & Fariss, M.W. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J. Pharmacol. Exp. Ther. 279, 1470–1483 (1996).
  CAS PubMed Google Scholar
• Blazka, M.E., Elwell, M.R., Holladay, S.D., Wilson, R.E. & Luster, M.I. Histology of acetaminophen-induced liver changes: role of interleukin 1α and tumor necrosis factor α. Toxicol. Pathol. 24, 181–189 (1996).
  Article CAS Google Scholar
• Tiegs, G., Hentschel, J. & Wendel, A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196–203 (1992).
  Article CAS Google Scholar
• Mochizuki, K. et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J. Hepatol. 24, 1–17 (1996).
  Article CAS Google Scholar
• Hayashi, N. & Mita, E. Fas system and apoptosis in viral hepatitis. J. Gastroenterol. Hepatol. 12, 9–10 (1997).
  Google Scholar
• Luo, K.-X et al. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. J. Viral Hepatitis 4, 303–307 (1997).
  Article CAS Google Scholar
• Okazaki, M., Hino, K., Fujii, K., Kobayashi, N. & Okita, K. Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 41, 2453–2458 (1996).
  Article CAS Google Scholar
• Sekine, K., Nishimaki, T., Suzuki, T. & Kasukawa, R. Expression of Fas antigen on hepatocytes in viral hepatitis patients. Fukushima J. Med. Sci. 43, 51–59 (1997).
  CAS PubMed Google Scholar
• Faubion, W.A. et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of fas. J. Clin. Invest. 103, 137–145 (1999).
  Article CAS Google Scholar
• Strand, S. et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat. Med. 4, 588–593 (1998).
  Article CAS Google Scholar
• Matsumura, R. et al. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjogren's syndrome. Clin. Exp. Rheumatol. 16, 561–568 (1998).
  CAS PubMed Google Scholar
• Afford, S.C. et al. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J. Exp. Med. 189, 441–446 (1999).
  Article CAS Google Scholar
• Seino, K.-I. et al. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113, 1315–1322 (1997).
  Article CAS Google Scholar
• Tagawa, Y., Sekikawa, K. & Iwakure, Y. Suppression of concanavalin A-induced hepatitis in INF-r−/− mice, but not in TNF-a−/− mice. J. Immunol. 159, 1418–1428 (1997).
  CAS PubMed Google Scholar
• Baker, B.F. et al. 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 272, 1994–2000 (1997).
  Article Google Scholar
• Hanecak, R. et al. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol. 70, 5203–5212 (1996).
  CAS PubMed PubMed Central Google Scholar
• Geary, R.S. et al. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Drug Metab. Dispos. 25, 1272–1281 (1997).
  CAS PubMed Google Scholar
• Leeds, J.M., Graham, M.J., Truong, L. & Cummins, L.L. Quantitation of phosphorothioate oligonucleotides in human plasma. Anal. Biochem. 235, 36–43 (1996).
  Article CAS Google Scholar